News | Mammography | September 09, 2015

Loyola Medicine Conducts Successful See, Test & Treat Free Cancer Screening

Event funded by the College of American Pathologists Foundation helps vulnerable women in underserved communities improve their health

Loyola University Medical Center, See Test & Treat, free cancer screening, CAP Foundation

September 9, 2015 — More than 50 women in need received free cervical and breast cancer screenings with same-day results as part of a recent See, Test & Treat program and health fair at Loyola University Medical Center. Funded by a grant from the College of American Pathologists (CAP) Foundation, this was the first See, Test & Treat program offered in Illinois.

“Many of the women we cared for had not had a Pap test or mammogram in more than 20 years, and thanks to the generous funding by the CAP Foundation, were able to receive care,” said Loyola Chair of Pathology Eva M. Wojcik, M.D., FCAP. “Seeing those signs of relief on the faces of women who were told their screenings came back normal was priceless.”

Wojcik led a team of more than 35 Loyola physicians and medical personnel for the cancer screenings. Women between the ages of 30 and 64 with Medicaid or who were uninsured qualified for the event.

The screening included a pelvic exam, a Pap test with same-day results, an HPV test, a breast exam and screening mammography, if appropriate. Displays and educational materials were also available to help women better understand their unique health needs. Financial and medical specialists were onsite to interact with participants, answer questions and provide information.

Through pathologists at select institutions around the United States, the See, Test & Treat program has provided free cervical and breast cancer screenings to thousands of women. The program is funded by donations to the CAP Foundation. The CAP Foundation plans to expand See, Test & Treat so that more pathologists can collaborate with their clinical colleagues to coordinate care teams and provide essential screening services to more vulnerable women across the country.

The Loyola University Medical Center event was also supported by Hologic Inc., the Community Memorial Foundation, the Coleman Foundation and Quest Diagnostics.

For more information: www.cap.org

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init